4.8 Article

The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition

期刊

NATURE COMMUNICATIONS
卷 13, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-33068-4

关键词

-

资金

  1. AMED Research Program on Emerging and Re-emerging Infectious Diseases [20fk0108539h0001, 20fk0108451s0101]
  2. AMED Research Program on HIV/AIDS [21fk0410046]
  3. JSPS KAKENHI [19H03703, 22H03119, 22H02877, 19K07623, 22K07089]
  4. Takeda Science Foundation
  5. IMAI MEMORIAL TRUST FOR AIDS RESEARCH
  6. Shin-Nihon Foundation of Advanced Medical Research
  7. Kumamoto University

向作者/读者索取更多资源

Mutations in the spike protein of SARS-CoV-2 can lead to escape from the neutralizing antibody response but still retain susceptibility to cellular immune response. A specific mutation, G446S, in the spike protein of the Omicron BA.1 variant affects antigen processing/presentation and enhances antiviral activity by vaccine-induced T cells.
Mutations in the spike of SARS-CoV-2 can result in the escape of the neutralising antibody response but may retain susceptibility to the cellular immune response. Here the authors show the G446S mutation in the spike protein of Omicron BA.1 is associated with altered antigen presentation and potentiates activation of specific T cell immunity. Although the Omicron variant of the SARS-CoV-2 virus shows resistance to neutralizing antibody, it retains susceptibility to the cellular immune response. Here we characterize vaccine-induced T cells specific for various SARS-CoV-2 variants and identified HLA-A*24:02-restricted CD8(+) T cells that strongly suppress Omicron BA.1 replication in vitro. Mutagenesis analyses revealed that a G446S mutation, located just outside the N-terminus of the cognate epitope, augmented TCR recognition of this variant. In contrast, no enhanced suppression of replication is observed against cells infected with the prototype, Omicron BA.2, and Delta variants that express G446. The enhancing effect of the G446S mutation is lost when target cells are treated with inhibitors of tripeptidyl peptidase II, a protein that mediates antigen processing. These ex vivo analysis and in vitro results demonstrate that the G446S mutation in the Omicron BA.1 variant affects antigen processing/presentation and potentiates antiviral activity by vaccine-induced T cells, leading to enhanced T cell recognition towards emerging variants.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据